OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017: Pharmaceuticals Market Research Reports

Pharmaceuticals Market Research Reports Pharmaceuticals Market Research Reports XML feed

2014 Benchmark Report Learn the ecommerce metrics that matter. From our sponsors

OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 Dec 30th 2013, 00:00 OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. While anterior uveitis patients represent the majority of patients, all but one of the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. The uveitis market is expected to grow between 2012 and 2017, due to the introduct...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions